Signal Desk · Markets

Sellas Life Sciences shares jump 156% after cancer vaccine data

2026-11-18 · 1 source · CNBC TV18 Market

In short

Sellas Life Sciences shares jumped 156% in one trading session. At the high, the stock was up 233% on Tuesday.

The move matters because it was the biggest single-day gain for the stock since 2020. Investors reacted to data on a cancer vaccine.

What the reporting says

Sellas Life Sciences shares surged 156% in a single session, with the stock reaching an intraday high of 233% on Tuesday, according to a CNBC TV18 Market summary. The move was described as the biggest single-day gain since 2020. The brief ties the rally to cancer vaccine data but gives no trial details or regulatory outcome.

Why it matters

Sellas Life Sciences saw its shares jump 156% in a single session, and the stock was up as much as 233% at the day’s high on Tuesday. The move is significant for shareholders and biotech traders tracking clinical-data-driven price swings.

Touches: Sellas Life Sciences, Healthcare, Markets, Companies

Sources